3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other
1
Conditions
Neoplasms
2
Thyroid Neoplasms
1
Psoriasis Vulgaris
1
Pelvic Neoplasms
1
Mucositis
1
Malnutrition
1
Infections
1
Gastrointestinal Neoplasms
1
Fibrosis
1
Enteritis
1
Colorectal Neoplasms
1
Carcinoma, Hepatocellular
1
Cancer Therapy-related Cardiovascular Toxicity
1
Anus Neoplasms
1
Adenomatous Polyposis Coli
1
Interventions
tocilizumab
1
golimumab
1
gilteritinib
1
Tumor Necrosis Factor Inhibitors
1
Trimethoprim, Sulfamethoxazole Drug Combination
1
Saline Solution
1
Probiotics
1
Polymerase Chain Reaction
1
Observation
1
Levofloxacin
1
Infliximab
1
Immunoenzyme Techniques
1
Etanercept
1
Docosahexaenoic Acids
1
Clarithromycin
1
Cefoxitin
1
Cefepime
1
Bronchoscopy
1
Bronchoalveolar Lavage
1
Antibiotic Prophylaxis
1
Adalimumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Unknown
×
Infections
×
Probiotics
×
Clear all
NCT03785938
2018-12-24
MaCROS
University of Leeds
Phase NA
Unknown
40 enrolled